Antihistamine Use in Chronic Kidney Disease
Second-generation H1 antihistamines are generally usable in chronic kidney disease (CKD), with dose adjustment required for several agents because of renal elimination and drug accumulation risk. [1] Renal impairment-based dosing should use the prescribing label thresholds (typically creatinine clearance [CrCl]) to prevent excessive exposure and adverse effects (especially sedation with renally cleared agents). [2]
Selection Algorithm
- Bilastine and fexofenadine may be preferred when renal impairment is present. [1]
- Cetirizine and levocetirizine require creatinine-clearance-based dose reduction because elimination is substantially influenced by kidney function. [2], [3]
- Loratadine does not require renal dose adjustment in renal insufficiency per the product labeling guidance. [4]
Medication Safety Considerations in CKD
Renally eliminated antihistamines show increased exposure with reduced kidney function. [3], [5] Sedation risk is an important adverse effect consideration for renally cleared second-generation agents. [1], [2] Dose selection should prioritize agents with minimal renal dose requirements when feasible. [1], [4]
Dosing Adjustment Using Creatinine Clearance (eGFR Proxy)
Creatinine clearance (CrCl) should be used as the labeled metric for dosing adjustments. [2], [3], [5] For practical dosing, labeled CrCl categories can be approximated from eGFR because the labels do not universally provide eGFR cutoffs. [2], [3], [5]
Cetirizine Dosing Adjustment
For patients aged ≥12 years with decreased renal function (CrCl 11–31 mL/min), cetirizine dose should be reduced to 5 mg once daily. [2] For patients on hemodialysis, cetirizine dose should be reduced to 5 mg once daily. [2]
Levocetirizine Dosing Adjustment
For mild renal impairment (CrCl 50–80 mL/min), levocetirizine should be reduced to 2.5 mg once daily. [3] For severe renal impairment (CrCl 10–30 mL/min), levocetirizine should be reduced to 2.5 mg twice weekly (every 3–4 days). [3]
Fexofenadine Dosing Adjustment
For adult patients with decreased renal function (mild, moderate, or severe renal impairment), fexofenadine should use a starting dose of 60 mg once daily. [5]
Loratadine Dosing Adjustment
No dosage adjustment is required in patients with renal insufficiency per product labeling guidance. [4]
Common Pitfalls to Avoid
Using non–renal-adjusted dosing of renally cleared antihistamines increases exposure risk in renal impairment. [3], [5] Selecting sedating renally cleared agents (such as cetirizine/levocetirizine) without renal dose reduction increases the risk of adverse central nervous system effects. [1], [2]
Targets and Goals of Therapy
The goal is symptom control at the lowest effective antihistamine exposure consistent with the patient’s renal function category. [2], [3], [5]